Home > Boards > US Listed > Medical - Drugs > GlaxoSmithKline (GSK)

Buy anything below 36 not much down side risk.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
stockboy Member Profile
Member Level 
Followed By 32
Posts 17,502
Boards Moderated 1
Alias Born 02/26/01
160x600 placeholder
Morphic Holding Sets IPO at 5 Million Shares; Sees Pricing at $14-$16 Apiece Dow Jones News - 6/14/2019 8:04:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/12/2019 1:32:53 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/7/2019 6:38:58 AM
Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options Business Wire - 6/6/2019 5:15:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/4/2019 6:22:29 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/3/2019 11:12:00 AM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/31/2019 2:05:17 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/24/2019 6:27:25 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/20/2019 9:58:51 AM
Thermo Fisher to Buy Ireland API Plant From GlaxoSmithKline Dow Jones News - 5/16/2019 6:40:00 AM
Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK PR Newswire (US) - 5/16/2019 5:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/13/2019 4:35:04 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/13/2019 4:06:10 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/8/2019 2:03:27 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/2/2019 4:16:42 PM
GlaxoSmithKline, Innoviva Asthma Inhaler Meets Primary Endpoint in Trial Dow Jones News - 5/2/2019 12:59:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/2/2019 12:49:25 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/1/2019 1:38:47 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/1/2019 1:19:50 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/1/2019 11:27:14 AM
GlaxoSmithKline Reports Growing Turnover and Profit in 1Q, Beating Market Expectations Dow Jones News - 5/1/2019 7:58:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/29/2019 8:28:21 AM
FDA Approves GlaxoSmithKline's Treatment for Pediatric Patients with Lupus Dow Jones News - 4/26/2019 4:31:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/26/2019 1:50:27 PM
GlaxoSmithKline Subsidiary Gets Positive Opinion for HIV Drug Dow Jones News - 4/26/2019 12:00:00 PM
stockboy Member Level  Sunday, 03/04/18 02:40:39 PM
Re: None
Post # of 137 
Buy anything below 36 not much down side risk.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist